Munir Pirmohamed
- Toxicology top 0.01%
- Pharmacovigilance and Adverse Drug Reactions 61
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 144
- Drug-Induced Adverse Reactions 114
- Drug-Induced Hepatotoxicity and Protection 51
- Geriatrics and Gerontology top 0.05%
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 144
- Drug-Induced Adverse Reactions 114
- Drug-Induced Hepatotoxicity and Protection 51
- Molecular Medicine top 0.2%
-
- Pharmaceutical studies and practices 78
- Pharmacological Effects and Toxicity Studies 37
-
- Drug Transport and Resistance Mechanisms 48
-
- Asthma and respiratory diseases 39
- Co-authors
- Dean J. NaisbittAna AlfirevicNeil R. KitteringhamB Kevin ParkAlasdair BreckenridgeAndrea JorgensenMia WadeliusThomas Walley
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Munir Pirmohamed
585 papers receiving 33.3k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Toxicology 3.5k
- Pharmacology 8.6k
- Geriatrics and Gerontology 2.7k
- Pharmacology 7.6k
- Molecular Medicine 1.4k
Countries citing papers authored by Munir Pirmohamed
This map shows the geographic impact of Munir Pirmohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munir Pirmohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munir Pirmohamed more than expected).
Fields of papers citing papers by Munir Pirmohamed
This network shows the impact of papers produced by Munir Pirmohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munir Pirmohamed. The network helps show where Munir Pirmohamed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Munir Pirmohamed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 42 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 13 | |
| 10 | 2020 | 14 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 12 | |
| 14 | 2019 | 19 | |
| 15 | 2018 | 30 | |
| 16 | 2010 | 62 | |
| 17 | 2006 | 4 | |
| 18 | 2004 | 11 | |
| 19 | Mechanisms of drug hypersensitivity in HIV-infected patients: the role of the immune system. | 2003 | 15 |
| 20 | Nurses' confidence in caring for patients with alcohol-related problems. | 1997 | 12 |
About Munir Pirmohamed
Munir Pirmohamed is a scholar working on Pharmacology, Toxicology and Geriatrics and Gerontology, having authored 601 papers that have together received 34.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (144 papers), Drug-Induced Adverse Reactions (114 papers), Pharmaceutical studies and practices (78 papers), Pharmacovigilance and Adverse Drug Reactions (61 papers), Drug-Induced Hepatotoxicity and Protection (51 papers), Drug Transport and Resistance Mechanisms (48 papers), Asthma and respiratory diseases (39 papers) and Pharmacological Effects and Toxicity Studies (37 papers). The work is most often cited by research in Toxicology (3.5k citations), Pharmacology (8.6k citations) and Geriatrics and Gerontology (2.7k citations). Munir Pirmohamed has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Dean J. Naisbitt, Ana Alfirevic, Neil R. Kitteringham, B Kevin Park, Alasdair Breckenridge, Andrea Jorgensen, Mia Wadelius, Thomas Walley, James L. Maggs and Paula Williamson.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.